Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 1/2 6Phase 3 4Phase 1 4Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 10Leukemia 10Myelodysplastic Syndromes 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Congenital Abnormalities 9Lymphoma, Follicular 8Hodgkin Disease 8Recurrence 7Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Primary Myelofibrosis 6Neoplasms, Plasma Cell 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Burkitt Lymphoma 6Blast Crisis 6Myeloproliferative Disorders 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myeloid, Accelerated Phase 5Dendritic Cell Sarcoma, Interdigitating 5Polycythemia Vera 4Anemia, Refractory, with Excess of Blasts 4Waldenstrom Macroglobulinemia 3Thrombocythemia, Essential 3

Interventions

fludarabine 5Cyclophosphamide 5Cyclosporine 4fludarabine phosphate 3Whole-Body Irradiation 3Imatinib Mesylate 3Therapeutics 2Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Methotrexate 2Hematologic Tests 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1nilotinib 1bosutinib 1Urinalysis 1Transplantation, Homologous 1Tetanus Toxoid 1Standard of Care 1Resistance Training 1Registries 1Radiotherapy 1Pharmaceutical Services 1Ondansetron 1Nurse Clinicians 1Modafinil 1Melphalan 1Health Promotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Busulfan × Clear all
NCT00176930 2021-01-22

Stem Cell Transplant for Hematological Malignancy

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
330 enrolled 25 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01499147 2018-11-08

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

University of Illinois at Chicago

Phase NA Completed
100 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡